ImmunityBio, Inc. IBRX Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s common stock shares outstanding?
- ImmunityBio, Inc. (IBRX) reported common stock shares outstanding of $77.07M in Q1 2026.
- How has ImmunityBio, Inc.'s common stock shares outstanding changed year-over-year?
- ImmunityBio, Inc.'s common stock shares outstanding increased by 88489.7% year-over-year, from $87K to $77.07M.
- What is the long-term trend for ImmunityBio, Inc.'s common stock shares outstanding?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s common stock shares outstanding has grown at a -77.5% compound annual growth rate (CAGR), from $29.75M to $17K.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.